These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18329196)

  • 1. In situ fiber optic method for long-term in vitro release testing of microspheres.
    Voisine JM; Zolnik BS; Burgess DJ
    Int J Pharm; 2008 May; 356(1-2):206-11. PubMed ID: 18329196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres.
    Zolnik BS; Burgess DJ
    J Control Release; 2008 Apr; 127(2):137-45. PubMed ID: 18282629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated temperature accelerated release testing of PLGA microspheres.
    Zolnik BS; Leary PE; Burgess DJ
    J Control Release; 2006 May; 112(3):293-300. PubMed ID: 16644055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acidic pH on PLGA microsphere degradation and release.
    Zolnik BS; Burgess DJ
    J Control Release; 2007 Oct; 122(3):338-44. PubMed ID: 17644208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactic acid triggers, in vitro, thiomersal to degrade protein in the presence of PLGA microspheres.
    Namur JA; Takata CS; Moro AM; Politi MJ; De Araujo PS; Cuccovia IM; Da Costa MH
    Int J Pharm; 2004 Apr; 273(1-2):1-8. PubMed ID: 15010124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLGA-based drug delivery systems: importance of the type of drug and device geometry.
    Klose D; Siepmann F; Elkharraz K; Siepmann J
    Int J Pharm; 2008 Apr; 354(1-2):95-103. PubMed ID: 18055140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of USP apparatus 4 method for microsphere in vitro release testing using Risperdal Consta.
    Rawat A; Stippler E; Shah VP; Burgess DJ
    Int J Pharm; 2011 Nov; 420(2):198-205. PubMed ID: 21889583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The release of cefazolin and gentamicin from biodegradable PLA/PGA beads.
    Wang G; Liu SJ; Ueng SW; Chan EC
    Int J Pharm; 2004 Apr; 273(1-2):203-12. PubMed ID: 15010144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. USP apparatus 4 method for in vitro release testing of protein loaded microspheres.
    Rawat A; Burgess DJ
    Int J Pharm; 2011 May; 409(1-2):178-84. PubMed ID: 21376792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release of amoxicillin from hydroxyapatite-coated poly(lactic-co-glycolic acid) microspheres.
    Xu Q; Czernuszka JT
    J Control Release; 2008 Apr; 127(2):146-53. PubMed ID: 18325617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyelectrolyte complex of chondroitin sulfate and peptide with lower pI value in poly(lactide-co-glycolide) microsphere for stability and controlled release.
    Park W; Na K
    Colloids Surf B Biointerfaces; 2009 Sep; 72(2):193-200. PubMed ID: 19414243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles.
    Manca ML; Loy G; Zaru M; Fadda AM; Antimisiaris SG
    Colloids Surf B Biointerfaces; 2008 Dec; 67(2):166-70. PubMed ID: 18835764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
    Bae SE; Son JS; Park K; Han DK
    J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated in vitro release testing method for naltrexone loaded PLGA microspheres.
    Andhariya JV; Choi S; Wang Y; Zou Y; Burgess DJ; Shen J
    Int J Pharm; 2017 Mar; 520(1-2):79-85. PubMed ID: 28153651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of polyethylene glycol on preparation of rifampicin-loaded PLGA microspheres with membrane emulsification technique.
    Ito F; Fujimori H; Honnami H; Kawakami H; Kanamura K; Makino K
    Colloids Surf B Biointerfaces; 2008 Oct; 66(1):65-70. PubMed ID: 18585903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation into the influence of drug lipophilicity on the in vivo absorption profiles from subcutaneous microspheres and in situ forming depots.
    Deadman CM; Kellaway IW; Yasin M; Dickinson PA; Murdan S
    J Control Release; 2007 Sep; 122(1):79-85. PubMed ID: 17638603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice.
    Murata N; Takashima Y; Toyoshima K; Yamamoto M; Okada H
    J Control Release; 2008 Mar; 126(3):246-54. PubMed ID: 18215787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
    Ohashi K; Kabasawa T; Ozeki T; Okada H
    J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanostructured microspheres produced by supercritical fluid extraction of emulsions.
    Della Porta G; Reverchon E
    Biotechnol Bioeng; 2008 Aug; 100(5):1020-33. PubMed ID: 18383122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.